Role of SHP-2 in fibroblast growth factor receptor-mediated suppression of myogenesis in C2C12 myoblasts

Molecular and Cellular Biology

Volumn 22, Issue 11, 2002, Pages 3875-3891

  Kontaridis, Maria I ^a   Liu, Xiangdong ^a   Zhang, Lei ^a   Bennett, Anton M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR SUBSTRATE 2ALPHA; GENE PRODUCT; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 2; SOMATOMEDIN C; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL DIVISION; CELL LINE; DNA-BINDING PROTEINS; ETS-DOMAIN PROTEIN ELK-1; FIBROBLAST GROWTH FACTOR 2; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE DEVELOPMENT; MUSCLES; PHOSPHOPROTEINS; PHOSPHORYLATION; POINT MUTATION; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

ANIMALIA; CERVUS ELAPHUS;

EID: 0036091468     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.11.3875-3891.2002     Document Type: Article

References (73)

1. Molecular cloning of a novel protein-tyrosine phosphatase, SH-PTP3, with sequence similarity to the src-homology region 2
2. A widely expressed human protein tyrosine phosphatase contains src homology 2 domains
3. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression
4. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor β to Ras
5. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases
6. Divergent roles of SHP-2 in ERK activation by leptin receptors
7. Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle
8. 1 phase and is repressed by fibroblast growth factor
9. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways
10. Potential involvement of FRS2 in insulin signaling
11. The molecular basis of skeletal muscle differentiation
12. Oncogenic Rasinduced proliferation requires autocrine fibroblast growth factor 2 signaling in skeletal muscle cells
13. Shp-2 tyrosine phosphatase: Signaling one cell or many
14. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases
15. Identification of a human src homology 2-containing protein tyrosine-phosphatase: A putative homolog of Drosophila corkscrew
16. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells
17. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation
18. Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms
19. A simplified system for generating recombinant adenoviruses
20. Crystal structure of the tyrosine phosphatase SHP-2
21. Loss of fibroblast growth factor receptors is necessary for terminal differentiation of embryonic limb muscle
22. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion
23. Involvement of an SHP-2-Rho small G protein pathway in hepatocyte growth factor/scatter factor-induced cell scattering
24. SHP-2 complex formation with the SHP-2 substrate-1 during C2C12 myogenesis
25. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway
26. The FGF receptor-1 tyrosine kinase domain regulates myogenesis but is not sufficient to stimulate proliferation
27. A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways
28. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal
29. 1 phase of the cell cycle
30. Tyrosyl phosphorylation and growth factor receptor association of the human corkscrew homologue, SH-PTP2
31. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor β
32. A new function for a phosphotyrosine phosphatase: Linking GRB2-Sos to a receptor tyrosine kinase
33. p38 mitogen-activated protein kinase activation is required for fibroblast growth factor-2-stimulated proliferation but not differentiation
34. The signaling adapter FRS-2 competes with She for binding to the nerve growth factor receptor TrkA. A model for discriminating proliferation and differentiation
35. Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: Antagonistic effects of JNK and p38 pathways
36. Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways
37. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells
38. MEF2: A transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation
39. Role of phosphatases in lymphocyte activation
40. Structure and function of SH2-domain-containing tyrosine phosphatases
41. Protein tyrosine phosphatases in signal transduction
42. Role of SH-PTP2, a protein-tyrosine phosphatase with src homology 2 domains, in insulin-stimulated ras activation
43. bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out
44. Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture
45. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors
46. Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps
47. Regulation of avian fibroblast growth factor receptor 1 (FGFR-1) gene expression during skeletal muscle differentiation
48. SNT, a differentiationspecific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells
49. Comparison of the intracellular signaling responses by three chimeric fibroblast growth factor receptors in PC12 cells
50. Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis
51. A role for RalGDS and a novel Ras effector in the Ras-mediated inhibition of skeletal myogenesis
52. Requirement of heparan sulfate for bFGF-mediated fibroblast growth factor and myoblast differentiation
53. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2
54. The protein tyrosine phosphatase shp-2 regulates RhoA activity
55. Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity
56. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
57. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation
58. The Rho family G proteins play a critical role in muscle differentiation
59. The SH2-containing protein tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development
60. The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells
61. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways
62. From form to function: Signaling by protein tyrosine phosphatases
63. Fibroblast growth factor and transforming growth factor β repress transcription of the myogenic regulatory gene MyoD1
64. Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle
65. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation
66. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584
67. The MyoD family and myogenesis: Redundancy, networks, and thresholds
68. Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3′-kinase
69. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2
70. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps
71. Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins
72. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1
73. Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts